Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Florentina Kosely"'
Autor:
Thomas Luft, Clemens-Martin Wendtner, Florentina Kosely, Aleksandar Radujkovic, Axel Benner, Felix Korell, Lars Kihm, Matthias F. Bauer, Peter Dreger, Uta Merle
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundThe coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and has evoked a pandemic that challenges public health-care systems worldwide. Endothelial cell dysfunction plays a key role
Externí odkaz:
https://doaj.org/article/4b85aab98f1f4f79b81dd0b27c5e6c45
Autor:
Peter Dreger, Aleksandar Radujkovic, Thomas Luft, Matthias F. Bauer, Felix Korell, Uta Merle, Florentina Kosely, Axel Benner, Lars P. Kihm, Clemens-Martin Wendtner
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology
Frontiers in Immunology
BackgroundThe coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and has evoked a pandemic that challenges public health-care systems worldwide. Endothelial cell dysfunction plays a key role
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef3cc4f02a8227035a729cadfd1d8631
https://doi.org/10.3389/fimmu.2021.634416
https://doi.org/10.3389/fimmu.2021.634416
Autor:
Sascha Dietrich, Carsten Müller-Tidow, Aleksandar Radujkovic, Mandy Wegner, Peter Dreger, Christoph Kimmich, Andrea Bondong, Anthony D. Ho, Thomas Luft, Michael Schmitt, Nora Liebers, Florentina Kosely, Petra Pavel, Peter Stadtherr, Ute Hegenbart, Lorenz Selberg, Anita Schmitt, Maria Luisa Schubert
Publikováno v:
Blood Adv
CD19-directed chimeric antigen receptor (CAR) T-cell treatment has evolved as standard of care (SOC) for multiply relapsed/refractory (R/R) large B-cell lymphoma (LBCL). However, its potential benefit over allogeneic hematopoietic cell transplantatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72a6615951b9aa1297508bc588253b7e
https://pubmed.ncbi.nlm.nih.gov/33351108
https://pubmed.ncbi.nlm.nih.gov/33351108
A 59 year old male patient was admitted to our hospital diagnosed with COVID-19 associated pneumonia. Upfront treatment with hydroxychloroquine and azithromycin was started. Because of clinical deterioration with ARDS, circulatory shock and increased
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70c9f36b138fbd17286e8e5f55ee29e9
https://doi.org/10.21203/rs.3.rs-26470/v1
https://doi.org/10.21203/rs.3.rs-26470/v1
Autor:
Iris, Breitkreutz, Natalia, Becker, Axel, Benner, Florentina, Kosely, Christoph, Heining, Jens, Hillengass, Gerlinde, Egerer, Anthony D, Ho, Hartmut, Goldschmidt, Marc S, Raab
Publikováno v:
Hematological oncology. 34(4)
Therapeutic options in heavily pretreated relapsed/refractory multiple myeloma patients are often very limited because of impaired bone marrow function. Bendamustine is effective in multiple myeloma and has a favourable toxicity profile. We hypothesi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e3edab99a8db1e781eed2e25fbebae35
https://pubmed.ncbi.nlm.nih.gov/25784529
https://pubmed.ncbi.nlm.nih.gov/25784529
Autor:
Patrick Wuchter, Anthony D. Ho, Gerlinde Egerer, Thomas Schmitt, Florentina Kosely, Johann-Wilhelm Schmier
Publikováno v:
Onkologie. 36(7-8)
Background: Prognosis and survival for patients with metastatic soft tissue sarcoma (STS) are dismal. Standard first-line systemic chemotherapy is anthracycline-based. Gemcitabine/docetaxel (GD) is a therapeutic option in the second-line setting. Her
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f719220770c1dfbeb721ecbf5a80fc4
https://pubmed.ncbi.nlm.nih.gov/23921760
https://pubmed.ncbi.nlm.nih.gov/23921760
Autor:
Ulrike Klein, Stefan Schmitt, Jens Hillengaß, Michael Hundemer, Florentina Kosely, Kai Neben, Hartmut Goldschmidt, Ute Hegenbart, Anthony D. Ho, Thomas Moehler
Publikováno v:
Annals of Hematology
Annals of Hematology, Springer Verlag, 2008, 88 (1), pp.67-71. ⟨10.1007/s00277-008-0561-1⟩
Annals of Hematology, Springer Verlag, 2008, 88 (1), pp.67-71. ⟨10.1007/s00277-008-0561-1⟩
International audience; The immunomodulatory drugs thalidomide and lenalidomide have enhanced activity in patients with multiple myeloma (MM). Their efficacy is increased with the addition of dexamethasone, but significant rates of venous thromboembo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c2b9e160d2e29ae0b2b54c2f07c9bdb
https://hal.archives-ouvertes.fr/hal-00477963
https://hal.archives-ouvertes.fr/hal-00477963
Publikováno v:
Blood. 114:4935-4935
Abstract 4935 Background Bisphosphonates have been proven to be effective in preventing or delaying skeletal complications in multiple myeloma with a significant improvement of the quality of life. Although these agents are usually well tolerated, os
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e4131d39211139c9b9b81a405f0ffaf
https://doi.org/10.1182/blood.v114.22.4935.4935
https://doi.org/10.1182/blood.v114.22.4935.4935